Working with legal archives
Our latest article explores legal archival gaps and using the fragments and remnants that remain to speculate on the performance of parliamentary human rights scrutiny.
Our latest article explores legal archival gaps and using the fragments and remnants that remain to speculate on the performance of parliamentary human rights scrutiny.
We are pleased to announce our latest paper: ‘“The tribunes of the people, the tongues o’ the common mouth”: Parliamentarians as representatives when scrutinising laws’
We are pleased to announce the publication of our latest paper, entitled ‘A “tick and flick” exercise: Movement and form in parliamentary human rights scrutiny’
Our latest paper is entitled ‘Imaging people who use drugs: How parliamentary actors picture and tell stories about the subjects of drug law reform’
If parliamentary scrutiny processes exclude public audiences, can they still reach considered conclusions on the human rights impacts of legislation on the public?
The latest article from our hepatitis C post-cure project explores the issue of electronic health record sharing surrounding hepatitis C in light of new laws.
Why don’t they complain? Our latest article takes up Sara Ahmed’s work on complaint to better understand why people affected by hepatitis C rarely make a complaint when they have experienced stigma and discrimination in healthcare settings.
In out latest article we explore the relationship between hepatitis C cure and how people affected by the virus feel about the cost of and their entitlement to health care.
Our latest article, published in Critical Public Health, explores the use and potential misuse of health data and its effect on people with or treated for hepatitis C.
What does ‘cure’ mean for people when treatment doesn’t bring about an end to the social effects of a disease? Our latest article explores the afterlives of hepatitis C in the era of cure.
Our latest paper, recently published in the journal of Law and Literature, investigates constructions of hepatitis C in Australian law both before and after new-generation treatments.
If human rights are an effective framework for the prevention of punitive approaches towards drugs, why haven’t they prevented them to date? The latest article from the GLaD team addresses this question.
Our latest article investigates the mainstreaming of hepatitis C care – a process known as ‘normalisation’ – and whether it can reduce the stigma and discrimination associated with the virus.
Our latest article considers how a ‘culture of human rights’ is defined in research into human rights charters across Australian jurisdictions, including the ACT.
In our latest article, we explore how alcohol and other drugs issues are considered in human rights scrutiny processes in Australian parliaments.
The law has the power to shape public understandings of hepatitis C infection, including how people with the virus understand themselves and their ability to avoid the stigma associated with it. The latest article from our project on the experiences of people treated for hepatitis C engages with the challenges posed by laws and policies devised in a pre-cure world.
Our new paper explores how this debate on roadside drug testing in the ACT unfolded.
We are excited to announce the publication of the first article from the ARC-funded project, ‘A world-first “post-human rights” framework for drug policy’. Co-authored by
Earlier in 2021, GLaD program researcher Emily Lenton led an article reporting on this work, titled ‘Upscaling HIV and hepatitis C testing in primary healthcare settings: Stigma-sensitive practice’ in the Australian Journal of Public Health.The article was co-authored with Jen Johnson, previously of the BBV Sector Development Program, and Dr Graham Brown. This article focuses on how healthcare settings can support the goal of upscaling HIV and hepatitis C testing in a way that delivers safe and stigma-free testing encounters.
We are excited to announce the publication of the first article from the project, ‘Addressing hepatitis C-related legal, policy and practice discrimination in a post-cure world’.